Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 12/20 | 0.43 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368948 | 0.86 | DPP7 (0.39) | ACHENOD1EPHX1SIRT6SIRT1 | |
| SCHEMBL8017621 | 0.85 | CAD (0.38) | NOD1 | |
| SCHEMBL18796573 | 0.84 | NOD1 (0.59) | ACHENOD1 | |
| SCHEMBL18796593 | 0.84 | NOD1 (0.59) | ACHENOD1 | |
| SCHEMBL18796584 | 0.84 | NOD1 (0.59) | ACHENOD1 | |
| SCHEMBL8013883 | 0.84 | NPY4R (0.42) | — | |
| SCHEMBL3043418 | 0.83 | TSHR (0.41) | NOD1EPHX1SIRT6SIRT1 | |
| Hydrochloric Acid SCHEMBL18796601 | 0.83 | NOD1 (0.58) | ACHENOD1 | |
| Hydrochloric Acid SCHEMBL10332244 | 0.83 | NOD1 (0.58) | ACHENOD1 | |
| Hydrochloric Acid SCHEMBL10332245 | 0.83 | NOD1 (0.58) | ACHENOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024074910-A1 | BIOCIDAL COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2024-04-11 | — | — | WO | claimed |
| EP-2046270-B1 | HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR MAINTAINING ANTICARIES ACTIVITY | COLGATE PALMOLIVE CO (US) | 2017-06-07 | — | — | EP | claimed |
| US-20170112823-A1 | COMPOSITIONS AND METHODS TO TREAT NEUROPATHY AND RELATED CONDITIONS | Health Naturally, LLC (US) | 2017-04-27 | — | — | US | claimed |
| EP-2265242-B1 | High fluoride ion recovery compositions | COLGATE PALMOLIVE CO (US) | 2017-03-08 | — | — | EP | claimed |
| EP-2136770-B1 | POLYMERIC ENCAPSULATES HAVING A QUATERNARY AMMONIUM SALT AND METHODS FOR PRODUCING THE SAME | COLGATE PALMOLIVE CO (US) | 2016-05-11 | — | — | EP | claimed |
| US-8900558-B2 | High fluoride ion oral care composition and method for maintaining anticaries activity | COLGATE-PALMOLIVE COMPANY (US) | 2014-12-02 | — | — | US | claimed |
| US-8568697-B2 | High fluoride ion recovery compositions | COLGATE-PALMOLIVE COMPANY (US) | 2013-10-29 | — | — | US | claimed |
| WO-2013103556-A1 | ANTIMICROBIAL COMPOSITION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2013-07-11 | — | — | WO | claimed |
| US-8178483-B2 | Extended oral release of broad spectrum antimicrobial agent; dentifrices; such as chitosan cetylpyridinium chloride microcapsules | COLGATE-PALMOLIVE COMPANY (US) | 2012-05-15 | — | — | US | claimed |
| EP-2265242-A1 | HIGH FLUORIDE ION RECOVERY COMPOSITIONS | Colgate-Palmolive Company (US) | 2010-12-29 | — | — | EP | claimed |
| EP-2136770-A1 | POLYMERIC ENCAPSULATES HAVING A QUATERNARY AMMONIUM SALT AND METHODS FOR PRODUCING THE SAME | Colgate-Palmolive Company (US) | 2009-12-30 | — | — | EP | claimed |
| WO-2009117644-A1 | HIGH FLUORIDE ION RECOVERY COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2009-09-24 | — | — | WO | claimed |
| US-20090238777-A1 | High Fluoride Ion Recovery Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2009-09-24 | — | — | US | claimed |
| EP-2046270-A2 | HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR MAINTAINING ANTICARIES ACTIVITY | Colgate-Palmolive Company (US) | 2009-04-15 | — | — | EP | claimed |
| WO-2008121518-A1 | POLYMERIC ENCAPSULATES HAVING A QUATERNARY AMMONIUM SALT AND METHODS FOR PRODUCING THE SAME | COLGATE-PALMOLIVE COMPANY (US) | 2008-10-09 | — | — | WO | claimed |
| US-20080242767-A1 | Polymeric Encapsulates Having a Quaternary Ammonium Salt and Methods for Producing the Same | COLGATE-PALMOLIVE COMPANY | 2008-10-02 | — | — | US | claimed |
| WO-2008005688-A2 | HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR MAINTAINING ANTICARIES ACTIVITY | COLGATE-PALMOLIVE COMPANY (US) | 2008-01-10 | — | — | WO | claimed |
| US-20080003187-A1 | High fluoride ion oral care composition and method for maintaining anticaries activity | COLGATE-PALMOLIVE COMPANY | 2008-01-03 | — | — | US | claimed |
| EP-4398868-A1 | AN ORAL CARE COMPOSITION COMPRISING A GLYCOLIPID AND A MILD SURFACTANT | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-20080003187-A1 | High fluoride ion oral care composition and method for maintaining anticaries activity | COLGATE-PALMOLIVE COMPANY | 2008-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170112823-A1 | COMPOSITIONS AND METHODS TO TREAT NEUROPATHY AND RELATED CONDITIONS | TNF, PMP22, IL6 | ACHE 4/4885NOD1 32/4885EPHX1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.